Medicare Part D Redesign: How Health Plans Can Prepare Using CMS Guidance
Clinical Optimization
SOLUTIONS
Clinical Optimization
The pharmaceutical landscape has never been more complex, with a myriad of high cost therapies for complex disease states. PSG understands the criticality of ensuring pharmacy programs optimize clinical outcomes while maintaining affordability for plans and members. Our team is comprised of experienced pharmacists who are industry thought leaders and provide unbiased clinical expertise so clients can make informed decisions to optimize their plans.
drug cost savings generated in 2023
lives represented in procurements over the last 3 years
years of pharmacy advocacy
Clinical optimization services include:
- Program review and recommendations on major market events, ensuring minimal member disruption and consistent clinical outcomes
- Review of the current and proposed utilization management and formulary programs, with specific recommendations for optimal management of the pharmacy program
- Support for your plan design strategy development for the upcoming plan year, including benchmarking of design elements and financial impact modeling
- Review of claims and utilization data and identification of cost-reduction opportunities, such as therapeutic class evaluation, disease intervention strategies, and generic substitution
Powered by Artemetrx, we utilize claims-level detail to quantify the current impact of pharmaceuticals and to forecast potential growth in utilization and drug spending. Our forecasting models include key assumptions regarding overall utilization, channel utilization, generic dispense rates, growth in key therapeutic classes, specialty drug utilization, anticipated impacts of new drug launches (including generics), and many other factors. These assumptions are driven by monitoring industry trends, data mined from PSG’s data warehouse, and client-specific data/trend analysis.
Related Posts
Contact PSG
"*" indicates required fields